CTRI/2022/06/043096
Not yet recruiting
Phase 2
A pilot study to assess the effect of intranasal oil instillation (Pratimarsha Nasya)on nasal barrier function among healthy individuals - NaSH study
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Central Council for Research in Ayurvedic Sciences
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Apparently healthy adults \[as determined by clinical history, general physical examination, Hematological and biochemical parameters (CBC, LFT, RFT)],
- •2\. Aged from 18 to 40 years age of any sex
Exclusion Criteria
- •b.Exclusion Criteria:
- •i.Nasal conditions: Septal deviations, hypertrophied turbinates, intra nasal masses, symptoms as nasal bleeding, chronic rhinitis
- •ii.Psychiatric or other conditions that in the opinion of the investigator may hamper study participation
- •iii.Known cases of uncontrolled diabetes mellitus, uncontrolled hypertension
- •iv.Pregnant or lactating women
- •v.Regularly practicing Jalneti, Pranayam, or any other intranasal treatment since one month from the day of screening
- •vi.On oral or intranasal steroid therapy since last 4 weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Efficacy Of Intranasal Tapentadol In Pain Management In Opioid Use DisorderHealth Condition 1: F112- Opioid dependenceCTRI/2021/09/036462GMC RH Patiala
Not yet recruiting
Phase 3
Investigating the preventive effect of intranasal dexamethasone in reducing nausea and vomiting after laparoscopic surgery in childreIRCT20180416039326N24Esfahan University of Medical Sciences42
Not yet recruiting
Phase 4
Evaluation of nasal administration of extract of Brahmi leaves (INDCA-NS) in the treatment of tension-type headacheCTRI/2020/10/028285Indus Biotech Private Limited
Completed
Phase 2
A Pilot Study In Adults And Adolescents With Irritant (Non-Allergic) RhinitisRhinitis, Allergic, PerennialNCT00730756GlaxoSmithKline102
Completed
Phase 2
Botulinum Toxin-A Compared with Cetirizine in the Treatment of Allergic RhinitisAllergic rhinitis.Vasomotor and allergic rhinitisIRCT201208261579N3Vice Chancellor for Research, Isfahan University of Medical Sciences50